These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11083634)

  • 1. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.
    Zhang L; Dhillon P; Yan H; Farmer S; Hancock RE
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3317-21. PubMed ID: 11083634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism.
    Dosunmu EF; Chaudhari AA; Bawage S; Bakeer MK; Owen DR; Singh SR; Dennis VA; Pillai SR
    BMC Microbiol; 2016 Aug; 16(1):192. PubMed ID: 27549081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa.
    Plesiat P; Aires JR; Godard C; Köhler T
    J Bacteriol; 1997 Nov; 179(22):7004-10. PubMed ID: 9371446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa.
    Piers KL; Hancock RE
    Mol Microbiol; 1994 Jun; 12(6):951-8. PubMed ID: 7934902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Moore RA; Hancock RE
    Antimicrob Agents Chemother; 1986 Dec; 30(6):923-6. PubMed ID: 3028253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane.
    Imamura Y; Higashiyama Y; Tomono K; Izumikawa K; Yanagihara K; Ohno H; Miyazaki Y; Hirakata Y; Mizuta Y; Kadota J; Iglewski BH; Kohno S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1377-80. PubMed ID: 15793115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide derived from phage display library exhibits antibacterial activity against E. coli and Pseudomonas aeruginosa.
    Sainath Rao S; Mohan KV; Atreya CD
    PLoS One; 2013; 8(2):e56081. PubMed ID: 23409125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
    Shang D; Meng X; Zhang D; Kou Z
    Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers.
    Zhang L; Scott MG; Yan H; Mayer LD; Hancock RE
    Biochemistry; 2000 Nov; 39(47):14504-14. PubMed ID: 11087404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mechanism of Killing by the Proline-Rich Peptide Bac7(1-35) against Clinical Strains of Pseudomonas aeruginosa Differs from That against Other Gram-Negative Bacteria.
    Runti G; Benincasa M; Giuffrida G; Devescovi G; Venturi V; Gennaro R; Scocchi M
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137800
    [No Abstract]   [Full Text] [Related]  

  • 11. Surface-localized spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic treatment and oxidative stress.
    Johnson L; Mulcahy H; Kanevets U; Shi Y; Lewenza S
    J Bacteriol; 2012 Feb; 194(4):813-26. PubMed ID: 22155771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic uptake pathways across the outer membrane of Pseudomonas aeruginosa.
    Moore RA; Woodruff WA; Hancock RE
    Antibiot Chemother (1971); 1987; 39():172-81. PubMed ID: 2823689
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.
    Srinivas N; Jetter P; Ueberbacher BJ; Werneburg M; Zerbe K; Steinmann J; Van der Meijden B; Bernardini F; Lederer A; Dias RL; Misson PE; Henze H; Zumbrunn J; Gombert FO; Obrecht D; Hunziker P; Schauer S; Ziegler U; Käch A; Eberl L; Riedel K; DeMarco SJ; Robinson JA
    Science; 2010 Feb; 327(5968):1010-3. PubMed ID: 20167788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78.
    Monteiro C; Fernandes M; Pinheiro M; Maia S; Seabra CL; Ferreira-da-Silva F; Costa F; Reis S; Gomes P; Martins MC
    Biochim Biophys Acta; 2015 May; 1848(5):1139-46. PubMed ID: 25680229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.
    Werneburg M; Zerbe K; Juhas M; Bigler L; Stalder U; Kaech A; Ziegler U; Obrecht D; Eberl L; Robinson JA
    Chembiochem; 2012 Aug; 13(12):1767-75. PubMed ID: 22807320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest of Homodialkyl Neamine Derivatives against Resistant
    Swain J; Dezanet C; Chalhoub H; Auquière M; Kempf J; Décout JL; Mingeot-Leclercq MP
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics.
    Mogi T; Kita K
    Cell Mol Life Sci; 2009 Dec; 66(23):3821-6. PubMed ID: 19701717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa.
    Yasir M; Dutta D; Willcox MDP
    Sci Rep; 2019 May; 9(1):7063. PubMed ID: 31068610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.
    Macfarlane ELA; Kwasnicka A; Hancock REW
    Microbiology (Reading); 2000 Oct; 146 ( Pt 10)():2543-2554. PubMed ID: 11021929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification.
    Piers KL; Brown MH; Hancock RE
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2311-6. PubMed ID: 7840562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.